PrestoDoctor Expands Cannabis Telemedicine Service to Texas
MESQUITE, NV / ACCESSWIRE / June 22, 2022 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated...
MESQUITE, NV / ACCESSWIRE / June 22, 2022 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated...
Additional contract for a new clinical trialParsortix system to be used for longitudinal monitoring of patients with unresectable solid tumoursGUILDFORD,...
Manufacturing facility would provide access to domestically manufactured vaccines against respiratory virusesModerna would expand its presence in the UK through...
The award program recognizes 50 distinguished companies for their leadership and success in the roofing and exteriors market. IRVING, Texas--(BUSINESS...
VANCOUVER, BC / ACCESSWIRE / June 21, 2022 / Gemina Laboratories Ltd. (the "Company" or "Gemina") (CSE:GLAB) (FRA:8I7) is pleased...
HILLSIDE, NJ / ACCESSWIRE / June 21, 2022 / Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") announced today Mr....
ADDIS ABABA, ETHIOPIA / ACCESSWIRE / June 21, 2022 / A year ago, the Mastercard Foundation and Africa CDC (www.AfricaCDC.org)...
Vancouver, British Columbia--(Newsfile Corp. - June 21, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBED) ("Lobe" or the "Company"),...
VoiceFriend broadens its best-of-breed communication and engagement solutions NEWTON, Mass.--(BUSINESS WIRE)--VoiceFriend, provider of the leading HIPAA-compliant, cloud-based communication platform for...
Company’s new solution enhancements enable providers to improve care coordination and collaboration through their patients’ post-acute care journey BALTIMORE--(BUSINESS WIRE)--#ACOs--Real...
Assets include issued patents, patent applications, products, clinical trial results, licensing agreementsApplied Biology generated approximately $8 million in revenues and...
Canalevia®-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for chemotherapy-induced...
Additional analyses to determine if a subgroup of patients and/or symptoms may have been responsive to treatmentCompany remains on track...
JACKSON CENTER, PA / ACCESSWIRE / June 21, 2022 / Recognizing the breadth of application of its patented extracorporeal treatment...
REDWOOD CITY, CA / ACCESSWIRE / June 21, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
FLORHAM PARK, NJ / ACCESSWIRE / June 21, 2022 / Hisamitsu America, a subsidiary of Hisamitsu Pharmaceutical Co., Inc., and...
SAN DIEGO, CA / ACCESSWIRE / June 21, 2022 / Ainos, Inc. (OTC PINK:AIMD) ("Ainos", or the "Company"), a diversified...
STOCKHOLM, SE / ACCESSWIRE / June 21, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
ANN ARBOR, MI / ACCESSWIRE / June 21, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
CAMBRIDGE, MA / ACCESSWIRE / June 21, 2022 / IIOT-OXYS, Inc. (OTC PINK:ITOX) ("Oxys") announces the execution of a Statement...